rxstatShortages › Leuprolide

Leuprolide shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Leuprolide products are in shortage in Canada (1 of 8 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
1 / 8
Reports on file
13
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
ZEULIDE DEPOT
3.75MG · KIT POWDER FOR SUSPENSION, SUSTAINED-RELEASE · VERITY PHARMACEUTICALS INC.
DIN 02429977 · since ?, no end estimate · Delay in shipping of the drug.
Resolved
ZEULIDE DEPOT
22.5MG · KIT POWDER FOR SUSPENSION, SUSTAINED-RELEASE · VERITY PHARMACEUTICALS INC.
DIN 02462699 · ended Aug 8, 2025 · Delay in shipping of the drug.
Resolved
ELIGARD
7.5MG · POWDER FOR SUSPENSION, SUSTAINED-RELEASE · TOLMAR INTERNATIONAL LTD.
DIN 02248239 · ended Sep 27, 2023 · Delay in shipping of the drug.
Discontinued
LUPRON
5MG · SOLUTION · ABBVIE CORPORATION
DIN 00727695
Resolved
ELIGARD
7.5MG · POWDER FOR SUSPENSION, EXTENDED-RELEASE · TOLMAR INTERNATIONAL LTD.
DIN 02248239 · ended May 20, 2022 · Delay in shipping of the drug.
Resolved
LUPRON DEPOT
11.25MG · POWDER FOR SUSPENSION, SUSTAINED-RELEASE · ABBVIE CORPORATION
DIN 02239834 · ended Mar 5, 2021 · Disruption of the manufacture of the drug.
Resolved
LUPRON DEPOT
30MG · POWDER FOR SUSPENSION, SUSTAINED-RELEASE · ABBVIE CORPORATION
DIN 02239833 · ended Mar 5, 2021 · Disruption of the manufacture of the drug.
Resolved
LUPRON DEPOT
3.75MG · POWDER FOR SUSPENSION, SUSTAINED-RELEASE · ABBVIE CORPORATION
DIN 00884502 · ended Jan 27, 2021 · Demand increase for the drug.
Resolved
LUPRON DEPOT
22.5MG · POWDER FOR SUSPENSION, SUSTAINED-RELEASE · ABBVIE CORPORATION
DIN 02230248 · ended Dec 11, 2020 · Disruption of the manufacture of the drug.
Resolved
LUPRON DEPOT
3.75MG · POWDER FOR SUSPENSION, SUSTAINED-RELEASE · ABBVIE CORPORATION
DIN 00884502 · ended Dec 6, 2019 · Other (Please describe in comments)
Resolved
LUPRON DEPOT
22.5MG · POWDER FOR SUSPENSION, SUSTAINED-RELEASE · ABBVIE CORPORATION
DIN 02230248 · ended Dec 6, 2019 · Other (Please describe in comments)
Resolved
LUPRON DEPOT
30MG · POWDER FOR SUSPENSION, SUSTAINED-RELEASE · ABBVIE CORPORATION
DIN 02239833 · ended Dec 6, 2019 · Other (Please describe in comments)

Showing 12 of 13 reports. All reports are on file with Health Canada.

What's happening

Leuprolide is currently affected by an active shortage report filed with Health Canada by VERITY PHARMACEUTICALS INC..

The reported cause is: delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Leuprolide is classified under “HORMONES AND RELATED AGENTS” (ATC L02AE).

Recent changes

Common questions

When will Leuprolide be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Leuprolide in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (hormones and related agents)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.